期刊
CURRENT OPINION IN PHARMACOLOGY
卷 56, 期 -, 页码 46-51出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.coph.2020.09.016
关键词
-
资金
- N.I.H. [DA043567, GM12313101]
- NSF [BCS1745823]
Nicotinic receptors are ligand-gated ion channels responding to acetylcholine and nicotine, playing a role in transducing environmental information in normal and disease states. Targeting the complex of the nicotinic receptor, including lynx1 accessory proteins, may be key to unlocking therapeutic potential.
Nicotinic receptors of the cholinergic system are ligand-gated ion channels, responding to the excitatory neurotransmitter, acetylcholine, and the addictive component of tobacco, nicotine. They help to transduce salient information in the environment by activating specific neural circuitry in normal and disease states. While nicotinic receptors are promising neurological and neuropsychiatric disorder targets, they have fallen out of favor after several late-stage clinical failures. Targeting the complex of the nicotinic receptor, including lynx1 accessory proteins, could be the key to unlocking the intractable nAChR for therapeutic development. Lynx1 binds to the extracellular face of the nAChR and acts as a critical modulator, suppressing memory, learning, and plasticity. Lynx1 removal in animal models leads to memory and plasticity enhancements, some of which have therapeutic relevance for neuropsychiatric and neurological disease. A review of the lynx1 accessory modulator and its role in modulating neuronal nAChRs will be discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据